Secreted amyloid-β precursor protein functions as a GABA B R1a ligand to modulate synaptic transmission

NMRPipe: A multidimensional spectral processing system based on UNIX pipes

Delaglio, F., Grzesiek, S., Vuister, G. W., Zhu, G., Pfeifer, J., & Bax, A. (1995) · Journal of Biomolecular NMR · doi:10.1007/bf00197809 · Cited by 15,961

Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination

Brünger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse‐Kunstleve, R. W., Jiang, J., Kuszewski, J. J., Nilges, M., Pannu, N., et al. (1998) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444998003254 · Cited by 15,723

An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database

Eng, J. K., McCormack, A. L., & Yates, J. R. (1994) · Journal of the American Society for Mass Spectrometry · doi:10.1016/1044-0305(94)80016-2 · Cited by 6,484

Large-scale analysis of the yeast proteome by multidimensional protein identification technology

Washburn, M. P., Wolters, D. A., & Yates, J. R. (2001) · Nature Biotechnology · doi:10.1038/85686 · Cited by 4,768

The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor

Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619

The CCPN data model for NMR spectroscopy: Development of a software pipeline

Vranken, W., Boucher, W., Stevens, T. J., Fogh, R. H., Pajon, A., Llinás, M., Ulrich, E. L., Markley, J. L., Ionides, J., & Laue, E. D. (2005) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.20449 · Cited by 3,222

The Xplor-NIH NMR molecular structure determination package

Schwieters, C. D., Kuszewski, J. J., Tjandra, N., & Clore, G. M. (2003) · Journal of Magnetic Resonance · doi:10.1016/s1090-7807(02)00014-9 · Cited by 2,371

Direct analysis of protein complexes using mass spectrometry

Link, A. J., Eng, J. K., Schieltz, D. M., Carmack, E., Mize, G. J., Morris, D. R., Garvik, B. M., & Yates, J. R. (1999) · Nature Biotechnology · doi:10.1038/10890 · Cited by 2,218

Evaluation of Multidimensional Chromatography Coupled with Tandem Mass Spectrometry (LC/LC−MS/MS) for Large-Scale Protein Analysis: The Yeast Proteome

Peng, J., Elias, J. E., Thoreen, C. C., Licklider, L., & Gygi, S. P. (2002) · Journal of Proteome Research · doi:10.1021/pr025556v · Cited by 1,652

APP Processing and Synaptic Function

Kamenetz, F., Tomita, T., Hsieh, H., Seabrook, G., Borchelt, D., Iwatsubo, T., Sisodia, S., & Malinow, R. (2003) · Neuron · doi:10.1016/s0896-6273(03)00124-7 · Cited by 1,644

Reduction of Dendritic Inhibition in CA1 Pyramidal Neurons in Amyloidosis Models of Early Alzheimer’s Disease

Ruiter, M., Herstel, L. J., & Wierenga, C. J. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200527 · Cited by 25

Methyltransferase-Like 3 Rescues the Amyloid-beta protein-Induced Reduction of Activity-Regulated Cytoskeleton Associated Protein Expression via YTHDF1-Dependent N6-Methyladenosine Modification

Xu, C., Huang, H., Zhang, M., Zhang, P., Li, Z., Liu, X., & Fang, M. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.890134 · Cited by 28

The potential of psychedelics for the treatment of Alzheimer's disease and related dementias

Winkelman, M., Szabó, A., & Frecska, E. (2023) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2023.07.003 · Cited by 33

Progressive Changes in Sleep and Its Relations to Amyloid-β Distribution and Learning in Single App Knock-In Mice

Maezono, S. E. B., Kanuka, M., Tatsuzawa, C., Morita, M., Kawano, T., Kashiwagi, M., Nondhalee, P., Sakaguchi, M., Saito, T., Saido, T. C., et al. (2020) · eNeuro · doi:10.1523/eneuro.0093-20.2020 · Cited by 30

Mechanisms and Regulation of Neuronal GABAB Receptor-Dependent Signaling

Rose, T. R., & Wickman, K. (2020) · Current topics in behavioral neurosciences · doi:10.1007/7854_2020_129 · Cited by 26

Selenium-Derivative Compounds: A Review of New Perspectives in the Treatment of Alzheimer’s Disease

Barbosa, F. A. R., Canto, R. F. S., Teixeira, K. F., de Souza, A. S., de Oliveira, A. S., & Braga, A. L. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220224161454 · Cited by 26

Macromolecular complex in recognition and proteolysis of amyloid precursor protein in Alzheimer’s disease

Zhou, R., Yang, G., & Shi, Y. (2019) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2019.09.004 · Cited by 26

Knock-in rats with homozygous PSEN1 Alzheimer mutation are viable and show selective γ-secretase activity loss causing low Aβ40/42 and high Aβ43

Tambini, M. D., & D'adamio, L. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.012542 · Cited by 26

Anticoagulants for Treatment of Alzheimer’s Disease

Grossmann, K. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200610 · Cited by 27

Nanoscale alterations in GABAB receptors and GIRK channel organization on the hippocampus of APP/PS1 mice

Martín‐Belmonte, A., Aguado, C., Alfaro‐Ruiz, R., Moreno‐Martínez, A. E., de la Ossa, L., Aso, E., Gómez-Acero, L., Shigemoto, R., Fukazawa, Y., Ciruela, F., et al. (2022) · Alzheimer s Research & Therapy · doi:10.1186/s13195-022-01078-5 · Cited by 22

Conservation and Innovation: Versatile Roles for LRP4 in Nervous System Development

DePew, A. T., & Mosca, T. J. (2021) · Journal of Developmental Biology · doi:10.3390/jdb9010009 · Cited by 24

Differential regulation of insulin signalling by monomeric and oligomeric amyloid beta-peptide

Molina-Fernández, R., Picón-Pagès, P., Barranco-Almohalla, A., Crepin, G., Herrera-Fernández, V., García-Elías, A., Fanlo-Ucar, H., Fernàndez‐Busquets, X., García‐Ojalvo, J., Oliva, B., et al. (2022) · Brain Communications · doi:10.1093/braincomms/fcac243 · Cited by 23

The Labyrinthine Landscape of APP Processing: State of the Art and Possible Novel Soluble APP-Related Molecular Players in Traumatic Brain Injury and Neurodegeneration

Masi, M., Biundo, F., Fiou, A., Racchi, M., Pascale, A., & Buoso, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076639 · Cited by 28

Neural oscillations during cognitive processes in an App knock-in mouse model of Alzheimer’s disease pathology

Jacob, S., Davies, G., Bock, M. D., Hermans, B., Wintmolders, C., Bottelbergs, A., Borgers, M., Theunis, C., Broeck, B. V., Manyakov, N. V., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-51928-w · Cited by 22

Secreted Amyloid Precursor Protein-Alpha Promotes Arc Protein Synthesis in Hippocampal Neurons

Livingstone, R. W., Elder, M. K., Barrett, M. C., Westlake, C. M., Peppercorn, K., Tate, W. P., Abraham, W. C., & Williams, J. M. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00198 · Cited by 22

Alterations of GABA B receptors in the APP/PS1 mouse model of Alzheimer's disease

Salazar, A., Osse, A. M. L., Ortiz, A. A., Murtishaw, A. S., & Kinney, J. W. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.10.013 · Cited by 26

Casein Kinase 2 dependent phosphorylation of eIF4B regulates BACE1 expression in Alzheimer’s disease

Bettegazzi, B., Monasor, L. S., Bellani, S., Codazzi, F., Restelli, L. M., Colombo, A. V., Deigendesch, N., Frank, S., Saito, T., Saido, T. C., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04062-3 · Cited by 20

The Impairment of Blood-Brain Barrier in Alzheimer’s Disease: Challenges and Opportunities with Stem Cells

López-Ornelas, A., Jiménez, A., Pérez‐Sánchez, G., Rodríguez-Pérez, C. E., Corzo‐Cruz, A., Velasco, I., & Estudillo, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231710136 · Cited by 22

Specific pharmacological and Gi/o protein responses of some native GPCRs in neurons

Xu, C., Zhou, Y., Liu, Y., Li, L., Liu, P., Wang, X., Xu, Z., Pin, J., Rondard, P., & Liu, J. (2024) · Nature Communications · doi:10.1038/s41467-024-46177-z · Cited by 21

Structural Basis of GABAB Receptor Regulation and Signaling

Fritzius, T., Stawarski, M., Isogai, S., & Bettler, B. (2020) · Current topics in behavioral neurosciences · doi:10.1007/7854_2020_147 · Cited by 21

Cooperation between neurovascular dysfunction and Aβ in Alzheimer’s disease

Wang, N., Yang, X., Zhao, Z., Liu, D., Wang, X., Tang, H., Zhong, C., Chen, X., Chen, W. K., & Meng, Q. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1227493 · Cited by 22

Osthole Improves Cognitive Function of Vascular Dementia Rats: Reducing Aβ Deposition via Inhibition NLRP3 Inflammasome

Liu, Y., Chen, X., Gong, Q., Shi, J., & Li, F. (2020) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b20-00112 · Cited by 20

Aη-α and Aη-β peptides impair LTP ex vivo within the low nanomolar range and impact neuronal activity in vivo

Mensch, M., Dunot, J., Yishan, S. M., Harris, S., Blistein, A., Avdiu, A., Pousinha, P. A., Giudici, C., Busche, M. A., Jedlička, P., et al. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00860-1 · Cited by 24

GABAB1e promotes the malignancy of human cancer cells by targeting the tyrosine phosphatase PTPN12

Wei, B., Zhu, Y., Yang, P., Han, Y. K., Wang, S., Wang, X., Xia, S., Song, X., Zhang, Z., Wang, S., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103311 · Cited by 20

Pinpointing the locus of GABAergic vulnerability in Alzheimer’s disease

Melgosa-Ecenarro, L., Doostdar, N., Radulescu, C. I., Jackson, J., & Barnes, S. J. (2022) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2022.06.017 · Cited by 20

Novel melatonin-trientine conjugate as potential therapeutic agents for Alzheimer’s disease

Li, L., Fan, Y., Wu, W., Bai, C., Jia, M., Hu, J.-P., Gao, H., Wang, T., Zhong, M., Huang, X., et al. (2022) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.106100 · Cited by 20

Reduction in GABAB on glia induce Alzheimer’s disease related changes

Osse, A. M. L., Pandey, R. S., Wirt, R. A., Ortiz, A. A., Salazar, A., Kimmich, M. J., Strom, E. N. T., Oblak, A. L., Lamb, B. T., Hyman, J. M., et al. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.03.002 · Cited by 21

Spatiotemporal insights of APP function

Dunot, J., Ribera, A., Pousinha, P. A., & Marie, H. (2023) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2023.102754 · Cited by 23

Gut microbiota metabolites: potential therapeutic targets for Alzheimer’s disease?

Zhang, S., Lu, J., Jin, Z., Xu, H., Zhang, D., Chen, J., & Wang, J. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1459655 · Cited by 25

Choroid plexus APP regulates adult brain proliferation and animal behavior

Arnaud, K., Moreira, V. O., Vincent, J., Dallérac, G., Dubreuil, C., Dupont, E., Richter, M., Müller, U. C., Rondi-Reig, L., Prochiantz, A., et al. (2021) · Life Science Alliance · doi:10.26508/lsa.202000703 · Cited by 17

The GABA B receptor mediates neuroprotection by coupling to G 13

Wang, Y., Gai, S., Zhang, W., Huang, X., Ma, S., Huo, Y., Wu, Y., Tu, H., Pin, J., Rondard, P., et al. (2021) · Science Signaling · doi:10.1126/scisignal.aaz4112 · Cited by 19

Alzheimer’s Disease—Rationales for Potential Treatment with the Thrombin Inhibitor Dabigatran

Grossmann, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094805 · Cited by 20

Extracellular vesicles from hiPSC-derived NSCs protect human neurons against Aβ-42 oligomers induced neurodegeneration, mitochondrial dysfunction and tau phosphorylation

Rao, S., Madhu, L. N., Babu, R. S., Shankar, G., Kotian, S., Nagarajan, A., Upadhya, R., Narvekar, E., Cai, J. J., & Shetty, A. K. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04324-3 · Cited by 19

Trans‐synaptic mechanisms orchestrated by mammalian synaptic cell adhesion molecules

Kim, J., Wulschner, L. E. G., Oh, W. C., & Ko, J. (2022) · BioEssays · doi:10.1002/bies.202200134 · Cited by 19

Amyloid‐β in Alzheimer's disease: Structure, toxicity, distribution, treatment, and prospects

Yu, Y., Yu, S., Battaglia, G., & Tian, X. (2024) · Ibrain · doi:10.1002/ibra.12155 · Cited by 19

VTA dopamine neurons are hyperexcitable in 3xTg-AD mice due to casein kinase 2-dependent SK channel dysfunction

Blankenship, H. E., Carter, K. A., Pham, K. D., Cassidy, N. T., Markiewicz, A. N., Thellmann, M. I., Sharpe, A. L., Freeman, W. M., & Beckstead, M. J. (2024) · Nature Communications · doi:10.1038/s41467-024-53891-1 · Cited by 18

Secreted APP Modulates Synaptic Activity: A Novel Target for Therapeutic Intervention?

Haass, C., & Willem, M. (2019) · Neuron · doi:10.1016/j.neuron.2019.01.058 · Cited by 18

Amyloid Beta in Alzheimer's Disease: Mechanisms, Biomarker Potential, and Therapeutic Targets

Ahmadi, S., Khaledi, S., Ahmadi, K., & Hassanzadeh, K. (2025) · CNS Neuroscience & Therapeutics · doi:10.1002/cns.70688 · Cited by 20

Neuronal function of Alzheimer's protein

Körte, M. (2019) · Science · doi:10.1126/science.aaw0636 · Cited by 17

Impaired plasticity of intrinsic excitability in the dentate gyrus alters spike transfer in a mouse model of Alzheimer's disease

Jiang, N., Cupolillo, D., Grosjean, N., Muller, E., Deforges, S., Mulle, C., & Amédée, T. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105345 · Cited by 17

Regulation of gene expression by the APP family in the adult cerebral cortex

Ji, H. Y., Shen, J., & Kang, J. (2022) · Scientific Reports · doi:10.1038/s41598-021-04027-8 · Cited by 18

Etiology and Clinical Significance of Network Hyperexcitability in Alzheimer’s Disease: Unanswered Questions and Next Steps

Samudra, N. P., Ranasinghe, K. G., Kirsch, H. E., Rankin, K. P., & Miller, B. L. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-220983 · Cited by 18

Ketogenic Diet as a Promising Non-Drug Intervention for Alzheimer’s Disease: Mechanisms and Clinical Implications

Xu, Y., Zheng, F., Zhong, Q., & Zhu, Y. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230002 · Cited by 20

A genome-wide association study identifies a gene network associated with paranoid schizophrenia and antipsychotics-induced tardive dyskinesia

Levchenko, А., Kanapin, A. A., Samsonova, A. A., Fedorenko, O. Y., Kornetova, E. G., Nurgaliev, T., Mazo, G. E., Semke, A. V., Kibitov, A. O., Bokhan, N. A., et al. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110134 · Cited by 16

How autism and Alzheimer’s disease are TrAPPed

Lahiri, D. K., Maloney, B., Wang, R., Sokol, D. K., Rogers, J. T., & Westmark, C. J. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-00928-8 · Cited by 17

MT5‐MMP controls APP and β‐CTF/C99 metabolism through proteolytic‐dependent and ‐independent mechanisms relevant for Alzheimer's disease

García‐González, L., Paumier, J., Louis, L., Pilat, D., Bernard, A., Stephan, D., Jullien, N., Checler, F., Nivet, E., Khrestchatisky, M., et al. (2021) · The FASEB Journal · doi:10.1096/fj.202100593r · Cited by 16

Neurexin‐β mediates the synaptogenic activity of amyloid precursor protein

Cvetkovska, V., Ge, Y., Xu, Q., Li, S., Zhang, P., & Craig, A. M. (2022) · The Journal of Neuroscience · doi:10.1523/jneurosci.0511-21.2022 · Cited by 17

Soluble amyloid-β precursor peptide does not regulate GABAB receptor activity

Rem, P. D., Sereikaité, V., Fernández‐Fernández, D., Reinartz, S., Ulrich, D., Fritzius, T., Trovò, L., Roux, S., Chen, Z., Rondard, P., et al. (2023) · eLife · doi:10.7554/elife.82082 · Cited by 17

Response of spike-wave discharges in aged APP/PS1 Alzheimer model mice to antiepileptic, metabolic and cholinergic drugs

Jin, N., Ziyatdinova, S., Gureviciene, I., & Tanila, H. (2020) · Scientific Reports · doi:10.1038/s41598-020-68845-y · Cited by 17

APPsα Rescues Tau-Induced Synaptic Pathology

Bold, C. S., Baltissen, D., Ludewig, S., Back, M. K., Just, J., Kilian, L., Erdinger, S., Banićević, M., Rehra, L., Almouhanna, F., et al. (2022) · Journal of Neuroscience · doi:10.1523/jneurosci.2200-21.2022 · Cited by 17

APPsα rescues CDK5 and GSK3β dysregulation and restores normal spine density in Tau transgenic mice

Baltissen, D., Bold, C. S., Rehra, L., Banićević, M., Fricke, J., Just, J., Ludewig, S., Buchholz, C. J., Körte, M., & Müller, U. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1106176 · Cited by 18

Structure of the photoreceptor synaptic assembly of the extracellular matrix protein pikachurin with the orphan receptor GPR179

Patil, D. N., Pantalone, S., Cao, Y., Laboute, T., Novick, S. J., Singh, S., Savino, S., Faravelli, S., Magnani, F., Griffin, P. R., et al. (2023) · Science Signaling · doi:10.1126/scisignal.add9539 · Cited by 15

Members of the vertebrate contactin and amyloid precursor protein families interact through a conserved interface

Karuppan, S. J., Vogt, A., Fischer, Z., Ladutska, A., Swiastyn, J., McGraw, H. F., & Bouyain, S. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101541 · Cited by 15

A Super-Resolved View of the Alzheimer’s Disease-Related Amyloidogenic Pathway in Hippocampal Neurons

Yu, Y., Gao, Y., Winblad, B. G., Tjernberg, L. O., & Schedin‐Weiss, S. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215008 · Cited by 14

Expression of the amyloid-β peptide in a single pair of C. elegans sensory neurons modulates the associated behavioural response

Sinnige, T., Ciryam, P. S., Casford, S., Dobson, C. M., de Bono, M., & Vendruscolo, M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0217746 · Cited by 18

Exploring the Genetic Association of the ABAT Gene with Alzheimer’s Disease

Zheng, Q., Bi, R., Xu, M., Zhang, D., Tan, L., Lu, Y.-P., & Yao, Y. (2021) · Molecular Neurobiology · doi:10.1007/s12035-020-02271-z · Cited by 14

Complement Activation in the Central Nervous System: A Biophysical Model for Immune Dysregulation in the Disease State

Peoples, N., & Strang, C. J. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.620090 · Cited by 14

Retinal Ganglion Cells Functional Changes in a Mouse Model of Alzheimer’s Disease Are Linked with Neurotransmitter Alterations

Araya, J., Bello, F., Shivashankar, G., Neira, D., Duran-Aniotz, C. A., Acosta, M. L., Escobar, M.-J., Hetz, C. A., Chacón, M., & Palacios, A. G. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201195 · Cited by 14

The reciprocal relationship between amyloid precursor protein and mitochondrial function

Strope, T. A., & Wilkins, H. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16183 · Cited by 15

Development of the SPEAR Model: Separate Phases of Encoding and Retrieval Are Necessary for Storing Multiple Overlapping Associative Memories

Hasselmo, M. E. (2024) · Hippocampus · doi:10.1002/hipo.23676 · Cited by 19

Sini‐San Regulates the NO‐cGMP‐PKG Pathway in the Spinal Dorsal Horn in a Modified Rat Model of Functional Dyspepsia

Wu, Z., Lu, X., Zhang, S., & Zhu, C. (2020) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2020/3575231 · Cited by 13

Molecular mechanism of secreted amyloid-β precursor protein in binding and modulating GABA B R1a

Feng, M., Song, Y., Chen, S. H., Zhang, Y., & Zhou, R. (2021) · Chemical Science · doi:10.1039/d0sc06946a · Cited by 13

Secreted Amyloid Precursor Protein Alpha (sAPPα) Regulates the Cellular Proteome and Secretome of Mouse Primary Astrocytes

Peppercorn, K., Kleffmann, T., Hughes, S. M., & Tate, W. P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087165 · Cited by 12

The Role of Beetroot Ingredients in the Prevention of Alzheimer’s Disease

Szymański, J., Szwajgier, D., & Baranowska‐Wójcik, E. (2023) · Applied Sciences · doi:10.3390/app13021044 · Cited by 14

Neurodevelopmental disorders and microcephaly: how apoptosis, the cell cycle, tau and amyloid-β precursor protein APPly

Sokol, D. K., & Lahiri, D. K. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1201723 · Cited by 11

Genomic stress and impaired DNA repair in Alzheimer disease

Neven, J., Issayama, L. K., Dewachter, I., & Wilson, D. M. (2024) · DNA repair · doi:10.1016/j.dnarep.2024.103678 · Cited by 12

Amylin and Secretases in the Pathology and Treatment of Alzheimer’s Disease

Singh, S. P., Yang, F., Sivils, A., Cegielski, V., & Chu, X. (2022) · Biomolecules · doi:10.3390/biom12070996 · Cited by 11

Chromosomal 3q amplicon encodes essential regulators of secretory vesicles that drive secretory addiction in cancer

Tan, X., Wang, S., Xiao, G.-Y., Wu, C., Liu, X., Zhou, B., Jiang, Y. L., Duose, D. Y., Xi, Y., Wang, J., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci176355 · Cited by 13

The different aspects of the GABAB receptor allosteric modulation

Kniazeff, J. (2020) · Advances in pharmacology · doi:10.1016/bs.apha.2020.02.003 · Cited by 11

A single-nuclei RNA sequencing study of Mendelian and sporadic AD in the human brain

Del-Aguila, J. L., Li, Z., Dube, U., Mihindukulasuriya, K. A., Budde, J. P., Fernandez, M. V., Ibanez, L., Bradley, J., Wang, F., Bergmann, K., et al. (2019) · doi:10.1101/593756 · Cited by 12

LRP1 at the crossroads of Aβ clearance and therapeutic targeting in Alzheimer’s disease

Deng, Y., Yin, H., Lu, Z., Lan, H., Liu, W., Zuo, C., Pan, N., Tian, X., & Gong, Q. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1669405 · Cited by 13

The association of GNB5 with Alzheimer disease revealed by genomic analysis restricted to variants impacting gene function

Zhang, J., Pandey, M., Awe, A., Lue, N., Kittock, C. M., Fikse, E., Degner, K. N., Staples, J., Mokhasi, N., Chen, W., et al. (2024) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2024.01.005 · Cited by 10

Novel Development and Prospects in Pathogenesis, Diagnosis, and Therapy of Alzheimer’s Disease

Teng, Z. (2024) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-230130 · Cited by 10

Enhanced accumulation of N-terminally truncated Aβ with and without pyroglutamate-11 modification in parvalbumin-expressing GABAergic neurons in idiopathic and dup15q11.2-q13 autism

Frackowiak, J., Mazur‐Kolecka, B., Mehta, P. D., & Węgiel, J. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-00923-8 · Cited by 10

Neuronal Trafficking of the Amyloid Precursor Protein—What Do We Really Know?

Lin, T., Tjernberg, L. O., & Schedin‐Weiss, S. (2021) · Biomedicines · doi:10.3390/biomedicines9070801 · Cited by 13

Protein Interactome of Amyloid-β as a Therapeutic Target

Lazarev, V. F., Dutysheva, E. A., Kanunikov, I. E., Guzhova, I. V., & Margulis, B. A. (2023) · Pharmaceuticals · doi:10.3390/ph16020312 · Cited by 9

Nanoarchitecture of CaV2.1 channels and GABAB receptors in the mouse hippocampus: Impact of APP/PS1 pathology

Martín‐Belmonte, A., Aguado, C., Alfaro‐Ruiz, R., Kulik, Á., de la Ossa, L., Moreno‐Martínez, A. E., Alberquilla, S., García‐Carracedo, L., Fernández, M., Fajardo‐Serrano, A., et al. (2024) · Brain Pathology · doi:10.1111/bpa.13279 · Cited by 11

Therapeutic potential and microRNA regulating properties of phytochemicals in Alzheimer’s disease

Kumari, A., Rahaman, A., Zeng, X., & Baloch, Z. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102439 · Cited by 9

The potential of acupuncture in the treatment of Alzheimer's disease: An exploration from traditional Chinese medicine to modern technology

Wang, M., Zhang, L., Huang, W., Huang, J., Luo, Y., & Huang, N. (2025) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2025.103222 · Cited by 10

Serotonin-mediated regulation of mitophagy in Alzheimer's disease: Mechanistic insights and therapeutic potential

Sultana, O. F., Bandaru, M., Bushra, M. A., Reddy, P. H., & Reddy, A. P. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102957 · Cited by 11

BACE2 deficiency impairs expression and function of endothelial nitric oxide synthase in brain endothelial cells

He, T., d’Uscio, L. V., & Katušić, Z. S. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15929 · Cited by 10

Review on pathogenesis and treatment of Alzheimer's disease

Cai, J., Liu, Y., & Fan, H. (2024) · Developmental Dynamics · doi:10.1002/dvdy.762 · Cited by 10

Interactions between daily sleep-wake rhythms, γ-secretase, and amyloid-β peptide pathology point to complex underlying relationships

Turton, S. M., Padgett, S., Jessup, M. T., Johnson, C. E., Buzinova, V. A., Barth, S. E., Köhler, K., Spearman, H. M., Macheda, T., Manauis, E. C., et al. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167840 · Cited by 7

A diagnostic index based on pseudo-continuous arterial spin labeling and T1-mapping improves efficacy in discriminating Alzheimer’s disease from normal cognition

Wang, X., Wang, D., Li, X., Wang, W., Gao, P., Lou, B., Pfeuffer, J., Zhang, X., Zhu, J., Li, C., et al. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.974651 · Cited by 8

Reduced expression of APLP2 in spinal GABAergic inhibitory neurons contributed to nerve injury-induced microglial activation and pain sensitization

Li, Y.-Z., Zhu, Y.-B., Ge, A.-N., Gao, M., Wang, K., Zeng, X.-R., Li, J., Li, Y., Xu, J.-Y., Bai, H.-H., et al. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109334 · Cited by 9

GABAergic signaling abnormalities in a novel CLU mutation Alzheimer's disease mouse model

Chen, C., Tang, X., Lan, Z., Wan, C., Su, H., Li, W., Li, Y., Zhou, X. W., Gao, H., Feng, X., et al. (2023) · Translational research · doi:10.1016/j.trsl.2023.05.003 · Cited by 8

Development of anticancer peptides with low hemolysis, high penetrating membrane activity, certain analgesic activity and the synergistic anticancer effect

Huo, Y., Ma, L., Zhang, M., Niu, M., Gu, X., Zhang, W., Yan, M., & Wei, G. (2022) · Biomaterials Science · doi:10.1039/d1bm02024b · Cited by 8

Identification of the probable structure of the sAPPα-GABA B R1a complex and theoretical solutions for such cases

Yang, H., Mei, J., Xu, W. W., Ma, X., Sun, B., & Ai, H. (2022) · Physical Chemistry Chemical Physics · doi:10.1039/d2cp00569g · Cited by 8

Spinal Inhibition of GABAB Receptors by the Extracellular Matrix Protein Fibulin-2 in Neuropathic Rats

Papon, M.-A., Feuvre, Y. L., Barreda‐Gómez, G., Favereaux, A., Farrugia, F., Bouali‐Benazzouz, R., Nagy, F., Rodríguez‐Puertas, R., & Landry, M. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00214 · Cited by 8

Digital spatial profiling of human parathyroid tumors reveals cellular and molecular alterations linked to vitamin D deficiency

Tu, C., Chang, W., Sosa, J. A., & Koh, J. (2023) · PNAS Nexus · doi:10.1093/pnasnexus/pgad073 · Cited by 7

Drofenine as a Kv2.1 inhibitor alleviated AD-like pathology in mice through Aβ/Kv2.1/microglial NLRP3/neuronal Tau axis

Lu, J., Zhou, Q., Zhu, D., Song, H., Xie, G., Zhao, X., Huang, Y., Cao, P., Wang, J., & Shen, X. (2024) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.11.010 · Cited by 7

Heat shock protein 70 in Alzheimer's disease and other dementias: A possible alternative therapeutic

Valle-Medina, A., Calzada‐Mendoza, C. C., Ocharan-Hernández, M. E., Jiménez‐Zamarripa, C. A., & Juárez‐Cedillo, T. (2025) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823241307021 · Cited by 7

Secreted Amyloid Precursor Protein Alpha, a Neuroprotective Protein in the Brain Has Widespread Effects on the Transcriptome and Proteome of Human Inducible Pluripotent Stem Cell-Derived Glutamatergic Neurons Related to Memory Mechanisms

Peppercorn, K., Kleffmann, T., Jones, O. D., Hughes, S. M., & Tate, W. P. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.858524 · Cited by 8

A Role for Drosophila Amyloid Precursor Protein in Retrograde Trafficking of L1-Type Cell Adhesion Molecule Neuroglian

Penserga, T., Kudumala, S., Poulos, R., & Godenschwege, T. A. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00322 · Cited by 6

Using stable isotope labeling to advance our understanding of Alzheimer’s disease etiology and pathology

Hark, T. J., & Savas, J. N. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15298 · Cited by 7

Intraneuronal accumulation of amyloid-β peptides as the pathomechanism linking autism and its co-morbidities: epilepsy and self-injurious behavior — the hypothesis

Frackowiak, J., & Mazur‐Kolecka, B. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1160967 · Cited by 8

Post-Translational Modifications of Platelet-Derived Amyloid Precursor Protein by Coagulation Factor XIII-A*

Hur, W. S., Juang, L. J., Mazinani, N., Munro, L., Jefferies, W. A., & Kastrup, C. J. (2020) · Biochemistry · doi:10.1021/acs.biochem.0c00450 · Cited by 7

CD2AP at the junction of nephropathy and Alzheimer’s disease

Vandal, M., Janmaleki, M., Rea, I. M., Gunn, C., Hirai, S., Biernaskie, J. A., Chun, J., Gordon, G. R., Shaw, A. S., Sanati‐Nezhad, A., et al. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00852-x · Cited by 9

Biological Mechanism-based Neurology and Psychiatry: A BACE1/2 and Downstream Pathway Model

Hampel, H. J., Lista, S., Caruso, G., Nisticò, R., Piccioni, G., Mercuri, N. B., Giorgi, F. S., Ferrarelli, F., Lemercier, P., Caraci, F., et al. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666211201095701 · Cited by 6

Age-Dependent Dysregulation of APP in Neuronal and Skin Cells from Fragile X Individuals

Cencelli, G., Pacini, L., Luca, A. D., Messia, I., Gentile, A., Kang, Y., Nobile, V., Tabolacci, E., Jin, P., Farace, M. G., et al. (2023) · Cells · doi:10.3390/cells12050758 · Cited by 6

A physiological function for sAPP?

Hurtley, S. M. (2019) · Science · doi:10.1126/science.363.6423.137-m

Secreted APP Modulates Synaptic Activity: A Novel Target for Therapeutic Intervention?

Haass, C., & Willem, M. (2019) · Neuron · doi:10.1016/j.neuron.2019.01.058 · Cited by 18

Molecular mechanism of secreted amyloid-β precursor protein in binding and modulating GABA B R1a

Feng, M., Song, Y., Chen, S. H., Zhang, Y., & Zhou, R. (2021) · Chemical Science · doi:10.1039/d0sc06946a · Cited by 13

[O1–07–06]: SOLUBLE AMYLOID PRECURSOR PROTEIN IS AN ISOFORM‐SPECIFIC GABA(B) RECEPTOR LIGAND THAT SUPPRESSES SYNAPTIC RELEASE PROBABILITY

Rice, H. C., Wierda, K. D. B., Frère, S. G. A., Vertkin, I., Molle, I. V., Ranaivoson, F. M., Comoletti, D., Savas, J. N., Slutsky, I., Strooper, B. D., et al. (2017) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2017.07.075 · Cited by 2

P1‐185: SECRETED AMYLOID PRECURSOR PROTEIN IS A GABABR1A LIGAND THAT SUPPRESSES SYNAPTIC VESICLE RELEASE

Rice, H. C., Wierda, K. D. B., Frère, S. G. A., Vertkin, I., Molle, I. V., Ranaivoson, F. M., Comoletti, D., Savas, J. N., Slutsky, I., Strooper, B. D., et al. (2018) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2018.06.189 · Cited by 1